Partly Cloudy
35°FPartly CloudyFull Forecast

BC-US--Meningitis Outbreak,3rd Ld-Writethru

FDA closer to meningitis source

Published: Tuesday, Nov. 13, 2012 1:15 a.m. CST

WASHINGTON (AP) – Federal health inspectors found numerous potential sources of contamination, including leaky ceilings and insects, at a drug-making facility that has the same founders as the specialty pharmacy linked to a deadly meningitis outbreak.

The Food and Drug Administration on Monday released the results of a monthlong inspection of Ameridose, a Westborough, Mass.-based company that makes injectable drugs. The agency’s report, posted online, lists a host of problems at the plant, ranging from manufacturing to sterility to quality control.

Inspectors said they found insects within 10 feet of a supposedly sterile area where drugs were manufactured. In another case, inspectors reported a bird flying into a room where drugs are stored.

Elsewhere, the report cites leaks and cracks in the ceiling and walls of a clean room used to manufacture sterile drugs. The same room contained “thick residues that were orange, brown, and green” on equipment used for sterilization.

National video

Reader Poll

Do you support protesters who have marched against the 2014 Chicago police killing of a black teenager who was shot 16 times by a white officer?
Yes, I support the protesters
No, I don't
Not sure
No opinion